Advertisement

Bendamustine/brentuximab vedotin

Acute renal failure and Pneumocystis pneumonia: 2 case reports

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Dumont M, et al. Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas. British Journal of Dermatology 181: 1315-1317, No. 6, Dec 2019. Available from: URL: http://doi.org/10.1111/bjd.18215

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Bendamustine/brentuximab vedotin. Reactions Weekly 1786, 47 (2020). https://doi.org/10.1007/s40278-020-73521-4

    Download citation